Načítá se...
Clinical Outcomes of TP53 Mutations in Cancers
High-throughput sequencing of cancer genomes is increasingly becoming an essential tool of clinical oncology that facilitates target identification and targeted therapy within the context of precision medicine. The cumulative profiles of somatic mutations in cancer yielded by comprehensive molecular...
Uloženo v:
| Vydáno v: | Cold Spring Harb Perspect Med |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Cold Spring Harbor Laboratory Press
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5008065/ https://ncbi.nlm.nih.gov/pubmed/27449973 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/cshperspect.a026294 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|